Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4541)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 26, 2025 (publication date) through Feb 17, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J Cardiol 2025; 17(6): 106147 [PMID: 40575425 DOI: 10.4330/wjc.v17.i6.106147] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J Cardiol 2025; 17(6): 106147 [PMID: 40575425 DOI: 10.4330/wjc.v17.i6.106147] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i6/106147.htm |
| Number | Citing Articles |
| 1 |
Inderjeet Singh Bharaj, Ajit Brar, Aayushi Kacheria, Karen Purewal, Austin Simister, Umabalan Thirupathy, Palak Gupta, Jasraj Kahlon, Juzer Munaim, Ei Ei Thwe, Samer Ibrahim, Valerie Martinez Vargas, Krishnaswami Vijayaraghavan. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo. Biomedicines 2025; 13(9): 2192 doi: 10.3390/biomedicines13092192
|
| 2 |
Johannes Bauer, Sophie Gensluckner, Julian Eberhardt, Alexander Akhgar, Christian Datz, Bernhard Iglseder, Patrick Langthaler, Eugen Trinka, Mathias Ausserwinkler, Georg Semmler, Bernhard Paulweber, Elmar Aigner, Bernhard Wernly. Atherosclerosis burden across subtypes of steatotic liver disease: A European cohort analysis. Nutrition, Metabolism and Cardiovascular Diseases 2026; : 104618 doi: 10.1016/j.numecd.2026.104618
|
| 3 |
Lavinia Alice Bălăceanu, Cristiana Grigore, Beatrice Bălăceanu-Gurău, Cristian-Dorin Gurău, Ioana Valeria Grigorescu, Ion Dina. Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological Mechanisms. Journal of Clinical Medicine 2026; 15(3): 1156 doi: 10.3390/jcm15031156
|
| 4 |
Yao Zhang, JiaXin Qi, Xia Chen, Lin Pang, Zhangwei Shi, Bowen Wei, Cheng Lian. Atrial fibrillation identification in patients with non-alcoholic fatty liver disease: a machine learning model based on immune-inflammatory markers. Diabetology & Metabolic Syndrome 2025; 18(1) doi: 10.1186/s13098-025-02025-8
|
| 5 |
Agata Morawska, Rafał Frankowski, Mikołaj Grabarczyk, Marcin Kosmalski, Monika Różycka-Kosmalska. Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life 2025; 15(11): 1713 doi: 10.3390/life15111713
|
| 6 |
Carlo Ratti, Mattia Malaguti, D'Aniello Emanuele, Antonio Bellasi, Gianluca Sanna. Understanding MASLD — from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis 2025; 409: 120495 doi: 10.1016/j.atherosclerosis.2025.120495
|
| 7 |
Tariq Alrasheed, Mohamed E. A. Mostafa, Mohammed A Madkhali, Hesham A Khairy. Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis. Frontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1734549
|